Header
With global biomedical innovation moving at an unparalleled pace, partnering fuels scientific progress and patient care. At Novartis, we're collaborating with innovators to address some of society's most challenging healthcare issues.
>50%
of our revenue comes from external innovation
~130
countries where Novartis products are sold
8.6 bn
invested in R&D in 2023 (USD)
Partnering focus areas
We are an innovative medicines focused company working on four therapeutic areas and five technology platforms.
Therapeutic areas
Partnering - Cardiovascular, renal & metabolic
Our efforts include use of early interventions and development of pioneering treatments, from prevention to management, as well as the creation of innovative access models. Our goal is to reduce and ultimately stop premature death and disability from cardiovascular disease.
Technology platforms
Partnering - Biotherapeutics
We strive to leverage cutting-edge science and technology to create novel biotherapeutics that deliver transformative impact in healthcare, and we are dedicated to advancing the production of high-quality biologics, with the goal of ultimately bringing safe and effective treatments to patients in need.
Other areas of interest
In addition to our areas of focus, Novartis also looks to partner in other disease, research and technology areas.
Partnering is at the core of our business
We collaborate to address some of society's most challenging healthcare issues and have a unified partnering strategy fueled by clarity, agility, accountability, and efficiency.
The Novartis Biome
We created the Novartis Biome as a bridge to help our partners become an extension of our own teams, working with us as easily and productively as possible to jointly innovate and co-develop digital solutions at scale.
